Insider · CIK 0001975404
Corey Michael Watton
Files at ZVRA (ZEVRA THERAPEUTICS, INC.). First filing Oct 16, 2024, latest Aug 12, 2026.
In brief
Corey Michael Watton files SEC Form 4 as director at ZVRA (ZEVRA THERAPEUTICS, INC.). Since Oct 16, 2024, Corey Michael Watton has reported 1 open-market buy worth $3,958 and 1 open-market sell worth $138k, the latest filed on Aug 12, 2026.
A track record needs three past buys with six months of prices behind them; Corey Michael Watton has 1, so none is measured yet.
The newest scored trade: sold $138k of ZVRA on Aug 10, 2026, filed Aug 12, 2026, scored 39 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $138k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ZVRA: ZEVRA THERAPEUTICS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 39Weak | ZEVRA THERAPEUTICS, INC. | $138k 12,300 shares | -87% | +59% from low-22% from high | |
| 25Weak | ZVRAbuy ZEVRA THERAPEUTICS, INC. | $3,958 500 shares | +50% | - |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | MOption exercise Common Stock | +12,300 | $4.97 | $61k | 14,100 | Aug 12, 2026 |
| Aug 10, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | SOpen-market sale Common Stock | -12,300 | $11.25 | $138k | 1,800 | Aug 12, 2026 |
| Aug 10, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | MOption exercise Stock Option (right to buy)derivative | -12,300 | $0.00 | $0 | 46,500 | Aug 12, 2026 |
| Jun 4, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | AGrant or award Stock Option (right to buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 18, 2026 |
| May 29, 2025 | ZVRA ZEVRA THERAPEUTICS, INC. | AGrant or award Stock Option (right to buy)derivative | +30,000 | $0.00 | $0 | 30,000 | May 30, 2025 |
| Oct 11, 2024 | ZVRA ZEVRA THERAPEUTICS, INC. | POpen-market purchase Common Stock | +500 | $7.92 | $3,958 | 1,500 | Oct 16, 2024 |
Questions about Corey Michael Watton
Answered from the filings on this page, as of the latest one.
Is Corey Michael Watton buying or selling?
In the last 12 months Corey Michael Watton reported 0 open-market buys worth $0 and 1 open-market sell worth $138k on SEC Form 4; the latest was sold $138k of ZVRA on Aug 10, 2026. Grants, option exercises and tax withholding are not counted.
How did Corey Michael Watton's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Corey Michael Watton has 1.
Where does Corey Michael Watton file Form 4?
Corey Michael Watton has filed Form 4 at ZVRA (ZEVRA THERAPEUTICS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.